Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | GBA1 | P04062 | 1/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.41 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.41 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.41 |
| ▸ | MANBA | O00462 | 1/20 | 0.41 |
| ▸ | IDUA | P35475 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | GUSB | P08236 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | PPARG | P37231 | 4/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.31 |
| ▸ | HBB | P68871 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7151964 | 1.00 | LMNA (0.50) | LMNAGBA1HIF1ADNMT1CTDSP1 | |
| SCHEMBL17956707 | 1.00 | LMNA (0.50) | LMNAGBA1HIF1ADNMT1CTDSP1 | |
| SCHEMBL977551 | 1.00 | LMNA (0.50) | LMNAGBA1HIF1ADNMT1CTDSP1 | |
| SCHEMBL15947392 | 1.00 | LMNA (0.50) | LMNAGBA1HIF1ADNMT1CTDSP1 | |
| SCHEMBL879339 | 1.00 | LMNA (0.50) | LMNAGBA1HIF1ADNMT1CTDSP1 | |
| SCHEMBL12189851 | 1.00 | LMNA (0.50) | LMNAGBA1HIF1ADNMT1CTDSP1 | |
| SCHEMBL15945043 | 1.00 | LMNA (0.50) | LMNAGBA1HIF1ADNMT1CTDSP1 | |
| SCHEMBL12762744 | 1.00 | LMNA (0.50) | LMNAGBA1HIF1ADNMT1CTDSP1 | |
| SCHEMBL9143456 | 0.92 | — | — | |
| SCHEMBL22106635 | 0.92 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5210089-A | Alpha and beta-mannosidase inhibitors | MONSANTO COMPANY (US) | 1993-05-11 | — | — | US | claimed |
| US-11286466-B2 | Ketoreductases | C-LECTA GMBH (DE) | 2022-03-29 | — | — | US | disclosed |
| US-20200216821-A1 | KETOREDUCTASES | C-LECTA GMBH (DE) | 2020-07-09 | — | — | US | disclosed |
| EP-3652328-A1 | KETOREDUCTASES | c-LEcta GmbH (DE) | 2020-05-20 | — | — | EP | disclosed |
| WO-2019012095-A1 | KETOREDUCTASES | C-LECTA GMBH (DE) | 2019-01-17 | — | — | WO | disclosed |
| US-9359581-B2 | Biotransformation using genetically modified Candida | SYNTHEZYME LLC (US) | 2016-06-07 | — | — | US | disclosed |
| US-20150218486-A1 | OXIDATION OF COMPOUNDS USING GENETICALLY MODIFIED CANDIDA | SYNTHEZYME LLC (US) | 2015-08-06 | — | — | US | disclosed |
| US-20150094483-A1 | BIOTRANSFORMATION USING GENETICALLY MODIFIED CANDIDA | INC., DNA TWOPOINTO, INC. | 2015-04-02 | — | — | US | disclosed |
| US-8597923-B2 | Oxidation of compounds using genetically modified Candida | SyntheZyme, LLC (US) | 2013-12-03 | — | — | US | disclosed |
| EP-2427559-A2 | BIOTRANSFORMATION USING GENETICALLY MODIFIED CANDIDA | DNA TWOPOINTO INC. (US) | 2012-03-14 | — | — | EP | disclosed |
| WO-2011008231-A2 | BIOTRANSFORMATION USING GENETICALLY MODIFIED CANDIDA | DNA 2.0 INC. (US) | 2011-01-20 | — | — | WO | disclosed |
| US-20100291653-A1 | BIOTRANSFORMATION USING GENETICALLY MODIFIED CANDIDA | INC., DNA TWOPOINTO, INC. | 2010-11-18 | — | — | US | disclosed |
| US-5210089-A | Alpha and beta-mannosidase inhibitors | MONSANTO COMPANY (US) | 1993-05-11 | — | — | US | disclosed |
| US-5210089-A | Alpha and beta-mannosidase inhibitors | MONSANTO COMPANY (US) | 1993-05-11 | — | — | US | disclosed |
| US-5210089-A | Alpha and beta-mannosidase inhibitors | MONSANTO COMPANY (US) | 1993-05-11 | — | — | US | disclosed |